COVID-19 Updates
Conference Coverage
FREEDOM COVID: Full-dose anticoagulation cut mortality but missed primary endpoint
In an in-hospital anticoagulation trial, the primary COVID endpoint was missed but a survival benefit is observed.
Feature
‘Breakthrough’ study: Diabetes drug helps prevent long COVID
Metformin led to a 42% drop in long COVID among people who had a mild to moderate COVID-19 infection.
From the Journals
COVID-19 shot appears to reduce diabetes risk, even after Omicron
Several studies conducted early in the pandemic suggested increased risks for both new-onset diabetes and cardiometabolic diseases following COVID...
From the Journals
Cardiac issues twice as likely with COVID plus high troponin
Hospitalized COVID-19 patients with high troponin levels were twice as likely to have cardiac abnormalities due to diverse causes in a large U.K....
Feature
Inflammation and immunity troubles top long-COVID suspect list
“I think that it’s a much more complex picture than just inflammation, or just autoimmunity, or just immune dysregulation,” says expert.
Feature
COVID emergency orders ending: What’s next?
There will be cost-sharing changes for COVID-19 vaccines, testing, and certain treatments.
Feature
Washington medical board charges doctor with spreading COVID misinformation
Doctors and professional organizations are trying to protect patients from any harm that results from mistruths spread by colleagues.
Commentary
Managing respiratory symptoms in the ‘tripledemic’ era
Is it COVID-19, flu, or even RSV?
Feature
Biden to end COVID emergencies in May
Doing so will have many effects, including the end of free vaccines and health services to fight the pandemic.
From the Journals
PCSK9 inhibitors for severe COVID? Pilot trial signals of benefit
“PCSK9 inhibition may represent a novel therapeutic pathway in addition to currently recommended therapeutic approaches for severe COVID-19.”
Feature
Doctors’ happiness has not rebounded as pandemic drags on
Nearly half of physicians said they were somewhat or very unhappy at work, compared with 75% before the pandemic